Related Experiment Videos
Rosaceiform eruption induced by erlotinib
Annalisa Patrizi1, Federica Bianchi, Iria Neri
1Department of Specialistic and Experimental Clinical Medicine, Division of Dermatology, University of Bologna, Italy. annalisa.patrizi@unibo.it
Dermatologic Therapy
|December 17, 2008
Abstract:
Adverse events with anti-epidermal growth factor receptor therapy mainly involve the skin. The most common cutaneous adverse event is an acneiform eruption, which occurs in more than 50% of cases. The aim of this paper is to report the case of rosaceiform eruption induced by erlotinib in an 81-year-old-man and to discuss the pathogenetic role of Demodex folliculorum mites, found in the present patient, using skin scraping.